Clinical Trial

A Trial of HRS-6213 in Healthy Subjects and Patients With Solid Tumors

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
The study is being conducted to evaluate the safety, radiation dosimetry, pharmacokinetics, and preliminary diagnostic efficacy of HRS-6213.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-08.
Status change: Not Yet Recruiting → Recruiting 2025-08-10
Trial Details
NCT Number NCT07070349
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Patients With Solid Tumors
Enrollment 48 participants
Start Date 2025-07-10
Primary Completion 2026-01 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-08-12